QQ客服 官方微博 反馈留言

浏览/检索结果: 共6条，第1-6条 帮助 限定条件 专题：复旦大学上海医学院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Heterogeneity of targeted lung lesion predicts platinum-based first-line therapy outcomes and overall survival for metastatic triple-negative breast cancer patients with lung metastasis: a "PET biopsy" method 期刊论文 CANCER MANAGEMENT AND RESEARCH, 2019, 卷号: 11 作者:  Zhao, Yannan;  Wang, Biyun;  Yang, Zhongyi;  Li, Yi;  Xie, Yizhao 收藏  |  浏览/下载：67/0  |  提交时间：2019/12/05 triple-negative breast cancer  chemotherapy  PET  tumor heterogeneity   Cisplatin shows greater efficacy than gemcitabine when combined with nab-paclitaxel in metastatic triple-negative breast cancer 期刊论文 SCIENTIFIC REPORTS, 2019, 卷号: 9 作者:  Xie, Yizhao;  Li, Yi;  Zhao, Yannan;  Gong, Chengcheng;  Hu, Xichun 收藏  |  浏览/下载：22/0  |  提交时间：2019/12/05 Treatment after Progression on Fulvestrant among Metastatic Breast Cancer Patients in Clinical Practice: a Multicenter, Retrospective Study 期刊论文 SCIENTIFIC REPORTS, 2019, 卷号: 9 作者:  Xie, Yizhao;  Zhao, Yannan;  Gong, Chengcheng;  Chen, Zhanhong;  Zhang, Yinbin 收藏  |  浏览/下载：22/0  |  提交时间：2019/12/05 Fulvestrant 500 mg Versus Exemestane in Postmenopausal Women With Metastatic Breast Cancer Resistant to Adjuvant Nonsteroidal Aromatase Inhibitors in Clinical Practice: A Multicenter Retrospective Study 期刊论文 CLINICAL BREAST CANCER, 2019, 卷号: 19, 期号: 3 作者:  Xie, Yizhao;  Li, Yi;  Zhang, Yinbin;  Zhang, Shuqun;  Li, Wei 收藏  |  浏览/下载：28/0  |  提交时间：2019/12/05 ER+ HER2(-) breast cancer  Endocrine sensitivity  Endocrine therapy  Fulvestrant  Metastatic breast cancer   Pretreatment F-18-FDG Uptake Heterogeneity Predicts Treatment Outcome of First-Line Chemotherapy in Patients with Metastatic Triple-Negative Breast Cancer 期刊论文 ONCOLOGIST, 2018, 卷号: 23, 期号: 10 作者:  Gong, Chengcheng;  Ma, Guang;  Hu, Xichun;  Zhang, Yingjian;  Wang, Zhonghua 收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05 F-18-fluorodeoxyglucose positron emission tomography  computed tomography  Triple-negative breast neoplasms  Metastatic breast cancer  Genetic heterogeneity  Prognosis   Prognostic Value of Tumor Heterogeneity on 18F-FDG PET/CT in HR+HER2-Metastatic Breast Cancer Patients receiving 500 mg Fulvestrant: a retrospective study 期刊论文 SCIENTIFIC REPORTS, 2018, 卷号: 8 作者:  Zhao, Yannan;  Liu, Cheng;  Zhang, Yingjian;  Gong, Chengcheng;  Li, Yi 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05